Watchlist Price Alert

Corvus Pharmaceuticals In... (CRVS)

NASDAQ: CRVS · Real-Time Price · USD

3.96

-0.30 (-7.04%)

At close: Jun 17, 2025, 3:42 PM

3.94

-0.51%

After-hours: Jun 17, 2025, 04:01 PM EDT

Corvus Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	151K	367K	460K	632K	743K	847K	842K	n/a
Gross Profit	n/a	-151K	-367K	-460K	-632K	-743K	-847K	-842K	-594K
Operating Income	-27.55M	-23.41M	-32.56M	-38.63M	-43.76M	-48.85M	-49.22M	-56.52M	-36.98M
Interest Income	n/a	n/a	654.00	n/a	540K	2.18M	2.28M	861K	601K
Pretax Income	-62.29M	-27.03M	-41.31M	-43.24M	-6M	-46.67M	-46.94M	-55.66M	-36.38M
Net Income	-62.29M	-27.03M	-41.31M	-43.24M	-6M	-46.67M	-46.94M	-55.66M	-36.38M
Selling & General & Admin	8.16M	6.73M	8.1M	9.52M	11.93M	10.88M	10.64M	10.22M	7.62M
Research & Development	19.39M	16.53M	24.47M	29.11M	31.83M	37.98M	38.59M	46.3M	29.36M
Other Expenses	n/a	n/a	587K	235K	37.46M	n/a	n/a	n/a	n/a
Operating Expenses	27.55M	23.26M	32.2M	38.63M	43.76M	48.85M	49.22M	56.52M	36.98M
Interest Expense	1.82M	1.58M	654K	15K	540K	2.18M	2.28M	n/a	601K
Selling & Marketing Expenses	n/a	-151K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	23.41M	32.56M	38.63M	43.76M	48.85M	49.22M	56.52M	36.98M
Income Tax Expense	n/a	n/a	8.74M	-5.04M	-1.17M	-2.92M	2.28M	-842K	-594K
Shares Outstanding (Basic)	60.98M	48.02M	46.55M	41.85M	29.48M	29.35M	27.51M	20.49M	15.42M
Shares Outstanding (Diluted)	60.98M	48.02M	46.55M	41.85M	29.48M	29.35M	27.51M	20.49M	15.42M
EPS (Basic)	-1.02	-0.56	-0.89	-1.03	-0.16	-1.49	-1.71	-2.72	-2.36
EPS (Diluted)	-1.02	-0.56	-0.89	-1.03	-0.16	-1.49	-1.71	-2.72	-2.36
EBITDA	-27.55M	-26.88M	-40.94M	-42.78M	-5.36M	-48.85M	-46.09M	-54.82M	-35.78M
EBIT	-60.47M	-27.03M	-41.31M	-43.24M	-6M	-48.85M	-46.94M	-55.66M	-36.38M
Depreciation & Amortization	32.92M	151K	367K	460K	632K	743K	847K	842K	594K